HUNTSMAN RONALD KIRK (Chairman & CEO) purchased 21.1% of their position (10K shares) of VIVOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $4.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/15/2023ACC: 0001493152-23-021525
DirectorOfficer10% Owner· Chairman & CEO
Since Dec 2020
+10K
Net shares
Net buyer
$4.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.49
Trade value
$4.90K
% of position
21.1%
6/14/2023
47.50K→57.50K
Total
Net shares
+10K
Net value
$4.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/14/2023 | P · Purchase | +10K | $0.49 | $4.90K | 21.1% | 47.50K | 57.50K |
| Total | +10K | $4.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74M
Total
1.74M indirect1.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74M | Indirect |
| Total | 1.74M | 1.74M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported